FRONTIER CAPITAL MANAGEMENT CO LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 479 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q2 2024$2,877,491
-58.7%
53,277
-47.8%
0.03%
-56.9%
Q1 2024$6,959,000
-56.4%
102,098
-60.0%
0.06%
-59.6%
Q4 2023$15,961,247
+32.6%
254,972
-3.8%
0.16%
+22.0%
Q3 2023$12,034,478
-43.0%
265,135
-29.4%
0.13%
-34.7%
Q2 2023$21,096,738
+906.4%
375,788
+710.8%
0.20%
+818.2%
Q1 2023$2,096,275
-7.7%
46,347
-17.0%
0.02%
-12.0%
Q4 2022$2,271,156
-89.1%
55,871
-82.5%
0.02%
-89.8%
Q3 2022$20,841,000
+103.5%
318,910
+89.3%
0.24%
+106.8%
Q2 2022$10,239,000
+10.3%
168,485
+13.9%
0.12%
+40.5%
Q1 2022$9,285,000
+1802.7%
147,917
+4542.7%
0.08%
+2000.0%
Q4 2020$488,000
+82.8%
3,186
-0.0%
0.00%
+100.0%
Q3 2020$267,000
-97.7%
3,187
-98.0%
0.00%
-98.1%
Q2 2020$11,719,000
+140.0%
159,458
+38.5%
0.10%
+89.1%
Q1 2020$4,882,000
+4.6%
115,112
+50.2%
0.06%
+61.8%
Q4 2019$4,668,000
+45.4%
76,636
+40.3%
0.03%
+47.8%
Q2 2018$3,210,00054,6310.02%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$37,781,00020.21%
Ariose Capital Management Ltd 37,900$2,872,0006.78%
EcoR1 Capital, LLC 1,077,483$81,652,0002.60%
NEA Management Company, LLC 1,590,002$120,490,0002.44%
ARK Investment Management 9,087,868$688,679,0002.08%
NIA IMPACT ADVISORS, LLC 62,609$3,876,0002.06%
Deuterium Capital Management, LLC 18,000$1,364,0002.02%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,200$8,192,0001.82%
PLUSTICK MANAGEMENT LLC 50,000$3,789,0001.76%
Nikko Asset Management Americas, Inc. 4,319,471$330,526,0001.74%
View complete list of CRISPR THERAPEUTICS AG shareholders